A

Active Director Director DIN 07982443
DIN 07982443 First appointment Nov 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2017
Shareholding value •••• Premium profile

About Anisha

Data last updated:

Anisha is a Director at Denz Pharmaceuticals Private Limited (since 2017). The company operates in Healthcare. Denz Pharmaceuticals Private Limited reported revenue of ₹1.30 Cr (FY 2019).

DIN 07982443
Primary Designation Director
Industry Healthcare
First Appointment 06 Nov 2017
Oldest Company Age 9 yrs
Largest company Denz Pharmaceuticals Private Limited · ₹1.30 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Denz Pharmaceuticals Private Limited U85110UP2017PTC095624
Director06 Nov 20172017₹1.30 Cr (FY 2019)Active

Board colleagues of Anisha

NameDINCompanyDesignation
Sanjay Kumar Sharma07874675Denz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Denz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anisha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anisha

Anisha currently holds 1 directorship: Denz Pharmaceuticals Private Limited (Director, since 06 Nov 2017, revenue ₹1.30 Cr (FY 2019)).

Anisha was first appointed on 06 Nov 2017 as Director at Denz Pharmaceuticals Private Limited.

The current boards of Anisha's companies include Sanjay Kumar Sharma (Denz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available